{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:44:29Z","timestamp":1790775869586,"version":"4.1.0"},"reference-count":150,"publisher":"Portland Press Ltd.","issue":"1","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,10,1]]},"abstract":"<jats:p>Mutations in the X-linked gene MECP2 (methyl CpG-binding protein 2) are the primary cause of the neurodevelopmental disorder RTT (Rett syndrome), and are also implicated in other neurological conditions. The expression product of this gene, MeCP2, is a widely expressed nuclear protein, especially abundant in mature neurons of the CNS (central nervous system). The major recognized consequences of MECP2 mutation occur in the CNS, but there is growing awareness of peripheral effects contributing to the full RTT phenotype. MeCP2 is classically considered to act as a DNA methylation-dependent transcriptional repressor, but may have additional roles in regulating gene expression and chromatin structure. Knocking out Mecp2 function in mice recapitulates many of the overt neurological features seen in RTT patients, and the characteristic postnatally delayed onset of symptoms is accompanied by aberrant neuronal morphology and deficits in synaptic physiology. Evidence that reactivation of endogenous Mecp2 in mutant mice, even at adult stages, can reverse aspects of RTT-like pathology and result in apparently functionally mature neurons has provided renewed hope for patients, but has also provoked discussion about traditional boundaries between neurodevelopmental disorders and those involving dysfunction at later stages. In the present paper we review the neurobiology of MeCP2 and consider the various genetic (including gene therapy), pharmacological and environmental interventions that have been, and could be, developed to attempt phenotypic rescue in RTT. Such approaches are already providing valuable insights into the potential tractability of RTT and related conditions, and are useful pointers for the development of future therapeutic strategies.<\/jats:p>","DOI":"10.1042\/bj20110648","type":"journal-article","created":{"date-parts":[[2011,9,14]],"date-time":"2011-09-14T18:04:05Z","timestamp":1316023445000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["MeCP2 and Rett syndrome: reversibility and potential avenues for therapy"],"prefix":"10.1042","volume":"439","author":[{"given":"Kamal\u00a0K.E.","family":"Gadalla","sequence":"first","affiliation":[{"name":"Institute of Neuroscience and Psychology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, U.K."},{"name":"School of Life Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, U.K."},{"name":"Pharmacology Department, Faculty of Medicine, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark\u00a0E.S.","family":"Bailey","sequence":"additional","affiliation":[{"name":"School of Life Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart\u00a0R.","family":"Cobb","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Psychology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2011,9,14]]},"reference":[{"key":"2021112214522719200_B1","first-page":"723","article-title":"[On a unusual brain atrophy syndrome in hyperammonemia in childhood]","volume":"116","author":"Rett","year":"1966","journal-title":"Wien Med. Wochenschr."},{"key":"2021112214522719200_B2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ana.410140412","article-title":"A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases","volume":"14","author":"Hagberg","year":"1983","journal-title":"Ann. Neurol."},{"key":"2021112214522719200_B3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"2021112214522719200_B4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jpeds.2005.10.037","article-title":"Rett syndrome in Australia: a review of the epidemiology","volume":"148","author":"Laurvick","year":"2006","journal-title":"J. Pediatr."},{"key":"2021112214522719200_B5","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann. Neurol."},{"key":"2021112214522719200_B6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.ejhg.5200618","article-title":"Parental origin of de novo MECP2 mutations in Rett syndrome","volume":"9","author":"Girard","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"key":"2021112214522719200_B7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrg1878","article-title":"Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized","volume":"7","author":"Bienvenu","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"2021112214522719200_B8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.gde.2006.04.009","article-title":"MeCP2 dysfunction in Rett syndrome and related disorders","volume":"16","author":"Moretti","year":"2006","journal-title":"Curr. Opin. Genet. Dev."},{"key":"2021112214522719200_B9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(92)90610-O","article-title":"Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA","volume":"69","author":"Lewis","year":"1992","journal-title":"Cell"},{"key":"2021112214522719200_B10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tibs.2005.12.008","article-title":"Genomic DNA methylation: the mark and its mediators","volume":"31","author":"Klose","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"2021112214522719200_B11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuron.2006.09.037","article-title":"Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation","volume":"52","author":"Zhou","year":"2006","journal-title":"Neuron"},{"key":"2021112214522719200_B12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/11.2.115","article-title":"Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation","volume":"11","author":"Shahbazian","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"2021112214522719200_B13","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/hmg\/10.17.1729","article-title":"Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry","volume":"10","author":"LaSalle","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"2021112214522719200_B14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/30764","article-title":"Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex","volume":"393","author":"Nan","year":"1998","journal-title":"Nature"},{"key":"2021112214522719200_B15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.molcel.2007.12.028","article-title":"MeCP2 binding to DNA depends upon hydration at methyl-CpG","volume":"29","author":"Ho","year":"2008","journal-title":"Mol. Cell"},{"key":"2021112214522719200_B16","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1093\/nar\/gkr005","article-title":"Biophysical analysis and small-angle X-ray scattering-derived structures of MeCP2-nucleosome complexes","volume":"39","author":"Yang","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"2021112214522719200_B17","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.1153252","article-title":"MeCP2, a key contributor to neurological disease, activates and represses transcription","volume":"320","author":"Chahrour","year":"2008","journal-title":"Science"},{"key":"2021112214522719200_B18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1128\/MCB.01593-06","article-title":"Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin","volume":"27","author":"Nikitina","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"2021112214522719200_B19","doi-asserted-by":"crossref","first-page":"17551","DOI":"10.1073\/pnas.0507856102","article-title":"Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2","volume":"102","author":"Young","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214522719200_B20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1042\/BSR20100124","article-title":"Brain-derived mecp2 complex supports a role for MeCP2 in RNA processing","volume":"31","author":"Long","year":"2011","journal-title":"Biosci. Rep."},{"key":"2021112214522719200_B21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.molcel.2010.01.030","article-title":"Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state","volume":"37","author":"Skene","journal-title":"Mol. Cell"},{"key":"2021112214522719200_B22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1073858403260995","article-title":"Rett syndrome: a prototypical neurodevelopmental disorder","volume":"10","author":"Neul","year":"2004","journal-title":"Neuroscientist"},{"key":"2021112214522719200_B23","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"2021112214522719200_B24","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat. Genet."},{"key":"2021112214522719200_B25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/85906","article-title":"Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice","volume":"27","author":"Chen","year":"2001","journal-title":"Nat. Genet."},{"key":"2021112214522719200_B26","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1073\/pnas.0401626101","article-title":"Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice","volume":"101","author":"Luikenhuis","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214522719200_B27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0896-6273(02)00768-7","article-title":"Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3","volume":"35","author":"Shahbazian","year":"2002","journal-title":"Neuron"},{"key":"2021112214522719200_B28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1523\/JNEUROSCI.2623-05.2006","article-title":"Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome","volume":"26","author":"Moretti","year":"2006","journal-title":"J. Neurosci."},{"key":"2021112214522719200_B29","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1523\/JNEUROSCI.0324-09.2009","article-title":"Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions","volume":"29","author":"Maezawa","year":"2009","journal-title":"J. Neurosci."},{"key":"2021112214522719200_B30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nn.2275","article-title":"Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology","volume":"12","author":"Ballas","year":"2009","journal-title":"Nat. Neurosci."},{"key":"2021112214522719200_B31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/brain\/awl022","article-title":"Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice","volume":"129","author":"Pelka","year":"2006","journal-title":"Brain"},{"key":"2021112214522719200_B32","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neuroscience.2007.02.009","article-title":"Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome","volume":"146","author":"Stearns","year":"2007","journal-title":"Neuroscience"},{"key":"2021112214522719200_B33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature09582","article-title":"Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes","volume":"468","author":"Chao","year":"2010","journal-title":"Nature"},{"key":"2021112214522719200_B34","doi-asserted-by":"crossref","first-page":"21966","DOI":"10.1073\/pnas.0912257106","article-title":"Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities","volume":"106","author":"Samaco","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214522719200_B35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005072-199503000-00006","article-title":"Selective dendritic alterations in the cortex of Rett syndrome","volume":"54","author":"Armstrong","year":"1995","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2021112214522719200_B36","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1212\/WNL.45.8.1581","article-title":"Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome","volume":"45","author":"Bauman","year":"1995","journal-title":"Neurology"},{"key":"2021112214522719200_B37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.expneurol.2009.12.007","article-title":"MeCP2 functions largely cell-autonomously, but also non-cell-autonomously, in neuronal maturation and dendritic arborization of cortical pyramidal neurons","volume":"222","author":"Kishi","year":"2010","journal-title":"Exp. Neurol."},{"key":"2021112214522719200_B38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuron.2007.08.018","article-title":"MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number","volume":"56","author":"Chao","year":"2007","journal-title":"Neuron"},{"key":"2021112214522719200_B39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.mcn.2009.07.009","article-title":"MeCP2 deficiency disrupts axonal guidance, fasciculation, and targeting by altering Semaphorin 3F function","volume":"42","author":"Degano","year":"2009","journal-title":"Mol. Cell. Neurosci."},{"key":"2021112214522719200_B40","doi-asserted-by":"crossref","first-page":"12560","DOI":"10.1073\/pnas.0506071102","article-title":"Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome","volume":"102","author":"Dani","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214522719200_B41","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1523\/JNEUROSCI.5503-09.2010","article-title":"Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice","volume":"30","author":"Kline","year":"2010","journal-title":"J. Neurosci."},{"key":"2021112214522719200_B42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1152\/jn.00826.2007","article-title":"Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome","volume":"99","author":"Medrihan","year":"2008","journal-title":"J. Neurophysiol."},{"key":"2021112214522719200_B43","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.cub.2006.02.062","article-title":"MeCP2-dependent transcriptional repression regulates excitatory neurotransmission","volume":"16","author":"Nelson","year":"2006","journal-title":"Curr. Biol."},{"key":"2021112214522719200_B44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJM199702273360907","article-title":"Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors","volume":"336","author":"Le\u00a0Roith","year":"1997","journal-title":"N. Engl J. Med."},{"key":"2021112214522719200_B45","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuroscience.2011.01.061","article-title":"Synaptic plasticity deficits in an experimental model of rett syndrome: long-term potentiation saturation and its pharmacological reversal","volume":"180","author":"Weng","year":"2011","journal-title":"Neuroscience"},{"key":"2021112214522719200_B46","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nn1860","article-title":"Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome","volume":"10","author":"Fernandez","year":"2007","journal-title":"Nat. Neurosci."},{"key":"2021112214522719200_B47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neulet.2007.12.039","article-title":"Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome","volume":"433","author":"Rueda","year":"2008","journal-title":"Neurosci. Lett."},{"key":"2021112214522719200_B48","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature711","article-title":"Mechanism for the learning deficits in a mouse model of neurofibromatosis type\u00a01","volume":"415","author":"Costa","year":"2002","journal-title":"Nature"},{"key":"2021112214522719200_B49","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.cub.2005.09.043","article-title":"The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type\u00a01","volume":"15","author":"Li","year":"2005","journal-title":"Curr. Biol."},{"key":"2021112214522719200_B50","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","article-title":"Reversal of learning deficits in a Tsc2+\/\u2212 mouse model of tuberous sclerosis","volume":"14","author":"Ehninger","year":"2008","journal-title":"Nat. Med."},{"key":"2021112214522719200_B51","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function","volume":"28","author":"Meikle","year":"2008","journal-title":"J. Neurosci."},{"key":"2021112214522719200_B52","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann. Neurol."},{"key":"2021112214522719200_B53","doi-asserted-by":"crossref","first-page":"10518","DOI":"10.1073\/pnas.1834280100","article-title":"A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4","volume":"100","author":"Bourtchouladze","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214522719200_B54","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.neuron.2004.05.021","article-title":"Chromatin acetylation, memory, and LTP are impaired in CBP+\/\u2212 mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration","volume":"42","author":"Alarcon","year":"2004","journal-title":"Neuron"},{"key":"2021112214522719200_B55","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.neuron.2005.01.038","article-title":"Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome","volume":"45","author":"McBride","year":"2005","journal-title":"Neuron"},{"key":"2021112214522719200_B56","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.neuron.2007.12.001","article-title":"Correction of fragile X syndrome in mice","volume":"56","author":"Dolen","year":"2007","journal-title":"Neuron"},{"key":"2021112214522719200_B57","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nn1845","article-title":"Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of \u03b1CaMKII inhibitory phosphorylation","volume":"10","author":"van\u00a0Woerden","year":"2007","journal-title":"Nat. Neurosci."},{"key":"2021112214522719200_B58","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.neuron.2008.12.007","article-title":"Reversing neurodevelopmental disorders in adults","volume":"60","author":"Ehninger","year":"2008","journal-title":"Neuron"},{"key":"2021112214522719200_B59","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.mcn.2008.01.005","article-title":"MeCP2 mutation causes distinguishable phases of acute and chronic defects in synaptogenesis and maintenance, respectively","volume":"37","author":"Palmer","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"2021112214522719200_B60","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.mcn.2004.07.006","article-title":"MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions","volume":"27","author":"Kishi","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"key":"2021112214522719200_B61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/WNR.0b013e3282f5661c","article-title":"A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome","volume":"19","author":"Schmid","year":"2008","journal-title":"NeuroReport"},{"key":"2021112214522719200_B62","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"2021112214522719200_B63","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.0610593104","article-title":"Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2","volume":"104","author":"Giacometti","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214522719200_B64","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/science.1206593","article-title":"Adult neural function requires MeCP2","volume":"333","author":"McGraw","year":"2011","journal-title":"Science"},{"key":"2021112214522719200_B65","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/hmg\/ddm185","article-title":"Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis","volume":"16","author":"Alvarez-Saavedra","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"2021112214522719200_B66","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/hmg\/ddn026","article-title":"Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice","volume":"17","author":"Jugloff","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"2021112214522719200_B67","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.1090842","article-title":"DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation","volume":"302","author":"Martinowich","year":"2003","journal-title":"Science"},{"key":"2021112214522719200_B68","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1523\/JNEUROSCI.23-07-02572.2003","article-title":"Upstream stimulatory factors are mediators of Ca2+-responsive transcription in neurons","volume":"23","author":"Chen","year":"2003","journal-title":"J. Neurosci."},{"key":"2021112214522719200_B69","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","article-title":"The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression","volume":"49","author":"Chang","year":"2006","journal-title":"Neuron"},{"key":"2021112214522719200_B70","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/sj.ejhg.5201682","article-title":"Increased skewing of X chromosome inactivation in Rett syndrome patients and their mothers","volume":"14","author":"Knudsen","year":"2006","journal-title":"Eur. J. Hum. Genet."},{"key":"2021112214522719200_B71","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/515525","article-title":"A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map","volume":"61","author":"Schanen","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"2021112214522719200_B72","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/jmg.38.7.435","article-title":"Segregation of a totally skewed pattern of X chromosome inactivation in four familial cases of Rett syndrome without MECP2 mutation: implications for the disease","volume":"38","author":"Villard","year":"2001","journal-title":"J. Med. Genet."},{"key":"2021112214522719200_B73","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/jmg.2006.045260","article-title":"Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation","volume":"44","author":"Archer","year":"2007","journal-title":"J. Med. Genet."},{"key":"2021112214522719200_B74","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ajmg.10557","article-title":"Balanced X chromosome inactivation patterns in the Rett syndrome brain","volume":"111","author":"Shahbazian","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"2021112214522719200_B75","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1086\/382228","article-title":"X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome","volume":"74","author":"Young","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"2021112214522719200_B76","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/hmg\/ddr066","article-title":"Age-dependent expression of MeCP2 in a heterozygous mosaic mouse model","volume":"20","author":"Smrt","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"2021112214522719200_B77","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1126\/science.6164095","article-title":"Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation","volume":"211","author":"Mohandas","year":"1981","journal-title":"Science"},{"key":"2021112214522719200_B78","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.ymthe.2005.06.086","article-title":"Rett syndrome is reversible and treatable by MeCP2 gene therapy into the striatum in mice","volume":"11","author":"Kosai","year":"2005","journal-title":"Mol. Ther."},{"key":"2021112214522719200_B79","doi-asserted-by":"crossref","first-page":"e6810","DOI":"10.1371\/journal.pone.0006810","article-title":"MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy","volume":"4","author":"Rastegar","year":"2009","journal-title":"PLoS ONE"},{"key":"2021112214522719200_B80","doi-asserted-by":"crossref","first-page":"e1687","DOI":"10.1542\/peds.2006-0395","article-title":"Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28","volume":"118","author":"Friez","year":"2006","journal-title":"Pediatrics"},{"key":"2021112214522719200_B81","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1136\/jmg.2004.023804","article-title":"Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome","volume":"42","author":"Meins","year":"2005","journal-title":"J. Med. Genet."},{"key":"2021112214522719200_B82","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1086\/444549","article-title":"Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males","volume":"77","author":"Van\u00a0Esch","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"2021112214522719200_B83","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/hmg\/ddh282","article-title":"Mild overexpression of MeCP2 causes a progressive neurological disorder in mice","volume":"13","author":"Collins","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"2021112214522719200_B84","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/hmg\/5.Supplement_1.1397","article-title":"Applications of gene therapy to the CNS","volume":"5","author":"Blomer","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"2021112214522719200_B85","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ymgme.2007.11.008","article-title":"Lentiviral-mediated gene therapy for murine mucopolysaccharidosis type\u00a0IIIA","volume":"93","author":"McIntyre","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"2021112214522719200_B86","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1073\/pnas.082011999","article-title":"Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors","volume":"99","author":"Brooks","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214522719200_B87","first-page":"119","article-title":"Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications","volume":"99","author":"Grieger","year":"2005","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"2021112214522719200_B88","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/S0140-6736(05)77740-0","article-title":"Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus","volume":"351","author":"Wagner","year":"1998","journal-title":"Lancet"},{"key":"2021112214522719200_B89","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood-2002-10-3296","article-title":"AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B","volume":"101","author":"Manno","year":"2003","journal-title":"Blood"},{"key":"2021112214522719200_B90","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/10430340460732490","article-title":"Phase I trial of intramuscular injection of a recombinant adeno-associated virus \u03b11-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults","volume":"15","author":"Flotte","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"2021112214522719200_B91","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.expneurol.2008.04.022","article-title":"Survival advantage of neonatal CNS gene transfer for late infantile neuronal ceroid lipofuscinosis","volume":"213","author":"Sondhi","year":"2008","journal-title":"Exp. Neurol."},{"key":"2021112214522719200_B92","doi-asserted-by":"crossref","first-page":"19559","DOI":"10.1073\/pnas.0706006104","article-title":"Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease","volume":"104","author":"Feigin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214522719200_B93","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"2021112214522719200_B94","doi-asserted-by":"crossref","first-page":"35ra42","DOI":"10.1126\/scitranslmed.3000830","article-title":"Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy","volume":"2","author":"Valori","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"2021112214522719200_B95","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1182\/blood-2004-07-2908","article-title":"Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model","volume":"105","author":"Arruda","year":"2005","journal-title":"Blood"},{"key":"2021112214522719200_B96","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.94.11.5804","article-title":"Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus","volume":"94","author":"Herzog","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214522719200_B97","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1182\/blood-2005-12-5115","article-title":"Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs","volume":"108","author":"Jiang","year":"2006","journal-title":"Blood"},{"key":"2021112214522719200_B98","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.1128\/JVI.72.11.8568-8577.1998","article-title":"Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue","volume":"72","author":"Duan","year":"1998","journal-title":"J. Virol."},{"key":"2021112214522719200_B99","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1128\/JVI.75.15.6969-6976.2001","article-title":"Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo","volume":"75","author":"Nakai","year":"2001","journal-title":"J. Virol."},{"key":"2021112214522719200_B100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nbd.2009.12.018","article-title":"Alterations of cortical and hippocampal EEG activity in MeCP2-deficient mice","volume":"38","author":"D'Cruz","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"2021112214522719200_B101","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.yebeh.2010.06.051","article-title":"Epilepsy in Rett syndrome: clinical and genetic features","volume":"19","author":"Pintaudi","year":"2010","journal-title":"Epilepsy Behav."},{"key":"2021112214522719200_B102","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/hipo.20389","article-title":"The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability","volume":"18","author":"Zhang","year":"2008","journal-title":"Hippocampus"},{"key":"2021112214522719200_B103","doi-asserted-by":"crossref","first-page":"10912","DOI":"10.1523\/JNEUROSCI.1869-07.2007","article-title":"Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome","volume":"27","author":"Ogier","year":"2007","journal-title":"J. Neurosci."},{"key":"2021112214522719200_B104","first-page":"71","article-title":"Rett syndrome: analysis of deaths in the British survey","volume":"6","author":"Kerr","year":"1997","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"2021112214522719200_B105","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1073\/pnas.0811228106","article-title":"Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice","volume":"106","author":"Simmons","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214522719200_B106","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2004.02.042","article-title":"Signaling by insulin-like growth factor 1 in brain","volume":"490","author":"Bondy","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"2021112214522719200_B107","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/nen.0b013e3180302078","article-title":"Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains","volume":"66","author":"Itoh","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2021112214522719200_B108","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice","volume":"106","author":"Tropea","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214522719200_B109","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cell.2010.10.016","article-title":"A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells","volume":"143","author":"Marchetto","year":"2010","journal-title":"Cell"},{"key":"2021112214522719200_B110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF02098506","article-title":"Reduced concentrations and increased metabolism of biogenic amines in a single case of Rett-syndrome: a postmortem brain study","volume":"68","author":"Brucke","year":"1987","journal-title":"J. Neural Transm."},{"key":"2021112214522719200_B111","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0887-8994(89)90049-0","article-title":"Rett syndrome: biogenic amines and metabolites in postmortem brain","volume":"5","author":"Lekman","year":"1989","journal-title":"Pediatr. Neurol."},{"key":"2021112214522719200_B112","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1523\/JNEUROSCI.4373-05.2005","article-title":"Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice","volume":"25","author":"Viemari","year":"2005","journal-title":"J. Neurosci."},{"key":"2021112214522719200_B113","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neulet.2008.09.045","article-title":"Tyrosine hydroxylase deficit in the chemoafferent and the sympathoadrenergic pathways of the Mecp2 deficient mouse","volume":"447","author":"Roux","year":"2008","journal-title":"Neurosci. Lett."},{"key":"2021112214522719200_B114","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/jnr.22312","article-title":"Progressive noradrenergic deficits in the locus coeruleus of Mecp2 deficient mice","volume":"88","author":"Roux","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"2021112214522719200_B115","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1051\/medsci\/20072310805","article-title":"[Pharmacological treatment of Rett syndrome improves breathing and survival in a mouse model]","volume":"23","author":"Roux","year":"2007","journal-title":"Med. Sci. (Paris)"},{"key":"2021112214522719200_B116","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.resp.2007.08.009","article-title":"Oral treatment with desipramine improves breathing and life span in Rett syndrome mouse model","volume":"160","author":"Zanella","year":"2008","journal-title":"Respir. Physiol. Neurobiol."},{"key":"2021112214522719200_B117","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0306-4522(96)00019-X","article-title":"Choline acetyltransferase activity and vesamicol binding in Rett syndrome and in rats with nucleus basalis lesions","volume":"73","author":"Wenk","year":"1996","journal-title":"Neuroscience"},{"key":"2021112214522719200_B118","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.nbd.2007.02.003","article-title":"Postnatal dietary choline supplementation alters behavior in a mouse model of Rett syndrome","volume":"26","author":"Nag","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"2021112214522719200_B119","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1523\/JNEUROSCI.5966-09.2010","article-title":"Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate","volume":"30","author":"Maezawa","year":"2010","journal-title":"J. Neurosci."},{"key":"2021112214522719200_B120","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.neuroscience.2010.03.065","article-title":"Diminished prevalence but preserved synaptic distribution of N-methyl-D-aspartate receptor subunits in the methyl CpG binding protein 2 (MeCP2)-null mouse brain","volume":"168","author":"Maliszewska-Cyna","year":"2010","journal-title":"Neuroscience"},{"key":"2021112214522719200_B121","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0028-3908(99)00060-X","article-title":"Memantine restores long term potentiation impaired by tonic N-methyl-D-aspartate (NMDA) receptor activation following reduction of Mg2+ in hippocampal slices","volume":"38","author":"Frankiewicz","year":"1999","journal-title":"Neuropharmacology"},{"key":"2021112214522719200_B122","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1152\/jn.00601.2009","article-title":"MeCP2 is required for normal development of GABAergic circuits in the thalamus","volume":"103","author":"Zhang","year":"2010","journal-title":"J. Neurophysiol."},{"key":"2021112214522719200_B123","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature09582","article-title":"Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes","volume":"468","author":"Chao","year":"2010","journal-title":"Nature"},{"key":"2021112214522719200_B124","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.resp.2011.02.002","article-title":"The benzodiazepine Midazolam mitigates the breathing defects of Mecp2-deficient mice","volume":"177","author":"Voituron","year":"2011","journal-title":"Respir. Physiol. Neurobiol."},{"key":"2021112214522719200_B125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.resp.2009.05.013","article-title":"Early breathing defects after moderate hypoxia or hypercapnia in a mouse model of Rett syndrome","volume":"168","author":"Voituron","year":"2009","journal-title":"Respir. Physiol. Neurobiol."},{"key":"2021112214522719200_B126","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.resp.2009.12.009","article-title":"Early abnormalities of post-sigh breathing in a mouse model of Rett syndrome","volume":"170","author":"Voituron","year":"2010","journal-title":"Respir. Physiol. Neurobiol."},{"key":"2021112214522719200_B127","doi-asserted-by":"crossref","first-page":"18208","DOI":"10.1073\/pnas.1012104107","article-title":"Correction of respiratory disorders in a mouse model of Rett syndrome","volume":"107","author":"Abdala","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214522719200_B128","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF02464911","article-title":"Aminoglycoside suppression at UAG, UAA and UGA codons in Escherichia coli and human tissue culture cells","volume":"217","author":"Martin","year":"1989","journal-title":"Mol. Gen. Genet."},{"key":"2021112214522719200_B129","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1017\/S1355838200000716","article-title":"Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system","volume":"6","author":"Manuvakhova","year":"2000","journal-title":"RNA"},{"key":"2021112214522719200_B130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1172\/JCI8055","article-title":"Correction of genetic disease by making sense from nonsense","volume":"104","author":"Kaufman","year":"1999","journal-title":"J. Clin. Invest."},{"key":"2021112214522719200_B131","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.22024","article-title":"Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy","volume":"67","author":"Malik","year":"2010","journal-title":"Ann. Neurol."},{"key":"2021112214522719200_B132","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nm0496-467","article-title":"Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations","volume":"2","author":"Howard","year":"1996","journal-title":"Nat. Med."},{"key":"2021112214522719200_B133","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/nm1197-1280","article-title":"Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line","volume":"3","author":"Bedwell","year":"1997","journal-title":"Nat. Med."},{"key":"2021112214522719200_B134","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejmg.2005.04.003","article-title":"Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update","volume":"49","author":"Philippe","year":"2006","journal-title":"Eur. J. Med. Genet."},{"key":"2021112214522719200_B135","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1203\/PDR.0b013e31819d9ebc","article-title":"Suppression of nonsense mutations in Rett syndrome by aminoglycoside antibiotics","volume":"65","author":"Brendel","year":"2009","journal-title":"Pediatr. Res."},{"key":"2021112214522719200_B136","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/jnr.22409","article-title":"Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in vitro","volume":"88","author":"Popescu","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"2021112214522719200_B137","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1531-8249(200008)48:2<164::AID-ANA5>3.0.CO;2-B","article-title":"Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy","volume":"48","author":"Howard","year":"2000","journal-title":"Ann. Neurol."},{"key":"2021112214522719200_B138","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"2021112214522719200_B139","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1021\/jm801640k","article-title":"Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations","volume":"52","author":"Nudelman","year":"2009","journal-title":"J. Med. Chem."},{"key":"2021112214522719200_B140","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.braindev.2005.03.021","article-title":"Management of young children with Rett disorder in the controlled multi-sensory (Snoezelen) environment","volume":"27","author":"Lotan","year":"2005","journal-title":"Brain Dev."},{"key":"2021112214522719200_B141","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.10094","article-title":"Environmental enrichment slows disease progression in R6\/2 Huntington's disease mice","volume":"51","author":"Hockly","year":"2002","journal-title":"Ann. Neurol."},{"key":"2021112214522719200_B142","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1523\/JNEUROSCI.5080-04.2005","article-title":"Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease","volume":"25","author":"Jankowsky","year":"2005","journal-title":"J. Neurosci."},{"key":"2021112214522719200_B143","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrn1970","article-title":"Enriched environments, experience-dependent plasticity and disorders of the nervous system","volume":"7","author":"Nithianantharajah","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"2021112214522719200_B144","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1111\/j.1460-9568.2008.06305.x","article-title":"Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome: Mecp2 gene dosage effects and BDNF expression","volume":"27","author":"Kondo","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"2021112214522719200_B145","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbr.2008.07.008","article-title":"Environmental enrichment alters locomotor behaviour and ventricular volume in Mecp2 1lox mice","volume":"196","author":"Nag","year":"2009","journal-title":"Behav. Brain Res."},{"key":"2021112214522719200_B146","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.biopsych.2009.12.022","article-title":"Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice","volume":"67","author":"Lonetti","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"2021112214522719200_B147","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbr.2005.04.009","article-title":"Environmental enrichment promotes improved spatial abilities and enhanced dendritic growth in the rat","volume":"163","author":"Leggio","year":"2005","journal-title":"Behav. Brain Res."},{"key":"2021112214522719200_B148","doi-asserted-by":"crossref","first-page":"12880","DOI":"10.1073\/pnas.97.23.12880","article-title":"Effects of environmental enrichment on gene expression in the brain","volume":"97","author":"Rampon","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214522719200_B149","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.neuroscience.2006.12.033","article-title":"Global changes in the hippocampal proteome following exposure to an enriched environment","volume":"145","author":"McNair","year":"2007","journal-title":"Neuroscience"},{"key":"2021112214522719200_B150","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1523\/JNEUROSCI.4225-08.2009","article-title":"MeCP2-mediated transcription repression in the basolateral amygdala may underlie heightened anxiety in a mouse model of Rett syndrome","volume":"29","author":"Adachi","year":"2009","journal-title":"J. Neurosci."}],"container-title":["Biochemical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/439\/1\/1\/668082\/bj4390001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/439\/1\/1\/668082\/bj4390001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T14:44:14Z","timestamp":1712846654000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemj\/article\/439\/1\/1\/45649\/MeCP2-and-Rett-syndrome-reversibility-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,14]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,10,1]]}},"URL":"https:\/\/doi.org\/10.1042\/bj20110648","relation":{},"ISSN":["0264-6021","1470-8728"],"issn-type":[{"value":"0264-6021","type":"print"},{"value":"1470-8728","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,14]]}}}